Literature DB >> 17654700

Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.

Maureen M J Guichelaar1, Jeffrey Schmoll, Michael Malinchoc, J Eileen Hay.   

Abstract

UNLABELLED: With early posttransplant bone loss, orthotopic liver transplantation (OLT) recipients experience a high rate of fracturing and some avascular necrosis (AVN), but little is known about the incidence of and predictive factors for these skeletal complications. We studied 360 consecutive patients who underwent transplantation for primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) and assessed both vertebral and nonvertebral (rib, pelvic, and femur) fractures in a protocolized fashion. Before OLT, 20% of the patients had experienced fracturing, and 1.4% of the patients had experienced AVN. Following OLT, there was a sharp increase in fracturing, with a 30% cumulative incidence of fractures at 1 year and 46% at 8 years after transplantation. In contrast to previous studies, there was a similar incidence of posttransplant vertebral and nonvertebral fractures. The greatest risk factors for posttransplant fracturing were pretransplant fracturing and the severity of osteopenia and posttransplant glucocorticoids. Nine percent of the liver recipients experienced AVN after OLT, and this correlated with pretransplant and posttransplant lipid metabolism, bone disease (bone mineral density and fracturing), and posttransplant glucocorticoids. A novel association between cholestasis and AVN was also identified, the mechanism for which is not known.
CONCLUSION: Fortunately, recent years have seen an increase in the bone mass of liver recipients and, along with this, less fracturing and less AVN. Nonetheless, 25% of patients undergoing OLT for chronic cholestatic liver disease still develop de novo fractures after OLT; this situation demands an ongoing search for effective therapeutic agents for these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654700     DOI: 10.1002/hep.21805

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  31 in total

Review 1.  Osteoporosis across chronic liver disease.

Authors:  M Guarino; I Loperto; S Camera; V Cossiga; C Di Somma; A Colao; N Caporaso; F Morisco
Journal:  Osteoporos Int       Date:  2016-02-04       Impact factor: 4.507

Review 2.  Cirrhosis-related musculoskeletal disease: radiological review.

Authors:  Ankur Arora; S Rajesh; Kalpana Bansal; Binit Sureka; Yashwant Patidar; Shalini Thapar; Amar Mukund
Journal:  Br J Radiol       Date:  2016-07-19       Impact factor: 3.039

Review 3.  Cord blood--an alternative source for bone regeneration.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  Stem Cell Rev Rep       Date:  2009-08-04       Impact factor: 5.739

Review 4.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 5.  Osteodystrophy in chronic liver diseases.

Authors:  Pasquale Mansueto; Antonio Carroccio; Aurelio Seidita; Gaetana Di Fede; Antonio Craxì
Journal:  Intern Emerg Med       Date:  2012-01-13       Impact factor: 3.397

6.  Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.

Authors:  Andrea D Branch; Burc Barin; Adeeb Rahman; Peter Stock; Thomas D Schiano
Journal:  Liver Transpl       Date:  2013-12-12       Impact factor: 5.799

7.  Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

Authors:  Elizabeth Shane; Adi Cohen; Emily M Stein; Donald J McMahon; Chiyuan Zhang; Polly Young; Kavita Pandit; Ronald B Staron; Elizabeth C Verna; Robert Brown; Susan Restaino; Donna Mancini
Journal:  J Clin Endocrinol Metab       Date:  2012-09-28       Impact factor: 5.958

Review 8.  Classical and emerging roles of vitamin D in hepatitis C virus infection.

Authors:  Julio A Gutierrez; Neil Parikh; Andrea D Branch
Journal:  Semin Liver Dis       Date:  2011-12-21       Impact factor: 6.115

9.  Osteoporosis in chronic liver disease: a case-control study.

Authors:  Ghizlane Wariaghli; Aziza Mounach; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  Rheumatol Int       Date:  2009-07-28       Impact factor: 2.631

10.  Joint Arthroplasties other than the Hip in Solid Organ Transplant Recipients.

Authors:  Arkan S Sayed-Noor
Journal:  Open Orthop J       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.